Innovating Works
H2020-MSCA-RR-2018
H2020-MSCA-RR-2018: MSCA for researchers at risk
Objective:Facilitate trans-national co-operation between European and national initiatives and programmes in support of researchers at risk, with a view to identifying and sharing good practices and raising the general standard of support to applicants, taking into account the diversity of actors.
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 04-12-2018.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Número mínimo de participantes.
Esta ayuda financia Proyectos: Objetivo del proyecto:

Objective:Facilitate trans-national co-operation between European and national initiatives and programmes in support of researchers at risk, with a view to identifying and sharing good practices and raising the general standard of support to applicants, taking into account the diversity of actors.


Scope:Funding will be given to a consortium of organisations with (i) experiences in supporting researchers at risk and (ii) knowledge of related European and national R&I funding programmes. “Researchers at risk” refers to researchers who are either at risk in their origin countries (due to discrimination, persecution, suffering and/or violence), or are seeking refuge out of these reasons or have recently found refuge in Europe.

Special attention will be given to assess the effectiveness of existing measures in European and national R&I programmes and to develop recommendations for policy-makers for effective programmes addressing support to researchers at risk to continue their scientific career in Europe, to find employment in line with their expertise and to support their integration in society in Europe.[1]

The consortium... ver más

Objective:Facilitate trans-national co-operation between European and national initiatives and programmes in support of researchers at risk, with a view to identifying and sharing good practices and raising the general standard of support to applicants, taking into account the diversity of actors.


Scope:Funding will be given to a consortium of organisations with (i) experiences in supporting researchers at risk and (ii) knowledge of related European and national R&I funding programmes. “Researchers at risk” refers to researchers who are either at risk in their origin countries (due to discrimination, persecution, suffering and/or violence), or are seeking refuge out of these reasons or have recently found refuge in Europe.

Special attention will be given to assess the effectiveness of existing measures in European and national R&I programmes and to develop recommendations for policy-makers for effective programmes addressing support to researchers at risk to continue their scientific career in Europe, to find employment in line with their expertise and to support their integration in society in Europe.[1]

The consortium should also build up cooperation with other related networks. It should also increase visibility of these R&I programmes to potential beneficiaries, especially in the non-academic sector. Therefore, particular focus should also be given to training schemes for researchers at risk, in line with the recommendation set out in the Report of the independent High Level Group on maximising the impact of EU Research & Innovation Programmes[2].

This Coordination and Support Action should enable the enablers by facilitating the establishment of sustainable and long-term support networks in Europe beyond its duration in order to be prepared with contacts, guidance and support structures to assist researchers at risk. This Action will support additional collaboration and peer-learning activities of existing networks and organisations.

The following activities should inter alia be envisaged in order to address these goals:

Explore available national and European R&I programmes for researchers at risk and produce targeted guidance materials,Training and guidance for the application process for the MSCA and other relevant support programmes,Support for career development for researchers at risk, in the academic and non-academic sector,Awareness-raising about funding and support opportunities among stakeholders in Europe through workshops and training seminars,Examine or run test-cases of supporting the integration of researchers at risk in relation to their individual academic backgrounds and their professional careers. The focus throughout these activities should be on topics specific to MSCA in relation to researchers at risk, in particular scientific excellence, skills and career development, intersectoral mobility, entrepreneurship, equal opportunities and inclusiveness, attractive working conditions, work/life balance, and lead to policy recommendations in this thematic area. It should not duplicate other actions foreseen under Horizon 2020, notably Science4Refugees. Furthermore, the activities should complement actions in Member States and Associated Countries.

In order to ensure maximum inclusiveness, the consortium should gather a group of legal entities from EU Member States and Associated Countries with broad experiences in the field of supporting and integrating researchers at risk in Europe and beyond. Representatives from other entities from EU Member States, Associated Countries or third countries from outside the consortium might however be invited to participate in the CSA's activities (e.g. workshops and conferences) for exchanging best practices.

The Commission considers that proposals requesting a contribution from the EU in the order of EUR 1.5 million would allow this specific challenge to be addressed appropriately. The requested duration of support should not exceed three years from the starting date specified in the grant agreement. Nevertheless, this does not preclude submission and selection of proposals requesting other amounts or duration.


Expected Impact:

An improved, sustainable and professionalised support network for researchers at risk across Europe, facilitating access to Horizon 2020 calls, creating level playing field for applicants to MSCA and other R&I programmes, and raising the average quality of submitted proposals. A more consistent and sustained level of preparedness for supporting researchers at risk in Europe.
Cross-cutting Priorities:Open ScienceInternational cooperation


[1]“Action Plan on the integration of third country nationals”. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions COM(2016) 377 final, p. 4-5

[2]“LAB – FAB – APP – Investing in the European future we want.” Report of the independent High Level Group on maximising the impact of EU Research & Innovation Programmes, p.13

ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: Objective:Facilitate trans-national co-operation between European and national initiatives and programmes in support of researchers at risk, with a view to identifying and sharing good practices and raising the general standard of support to applicants, taking into account the diversity of actors. Objective:Facilitate trans-national co-operation between European and national initiatives and programmes in support of researchers at risk, with a view to identifying and sharing good practices and raising the general standard of support to applicants, taking into account the diversity of actors.
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Purchase costs.
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
Subcontracting costs.
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 5:. Los elementos básicos de la innovación son integrados de manera que la configuración final es similar a su aplicación final, es decir que está listo para ser usado en la simulación de un entorno real. Se mejoran los modelos tanto técnicos como económicos del diseño inicial, se ha identificado adicionalmente aspectos de seguridad, limitaciones ambiéntales y/o regulatorios entre otros. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
1. Eligible countries: described in Annex A of the Work Programme.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
2. Eligibility and admissibility conditions: described in the MSCA part of the WorkProgramme.
Only legal entities from EU Member States and Associated Countries are eligible to participate in this action as beneficiaries as the aim of the action is to focus on European and national R&I programmes in Europe to support researchers at risk.
Proposal page limits and layout: please refer to Part B of the proposal template in the submission system below.
3. Evaluation:
Evaluation criteria, scoring and thresholds are described in Annex H of the Work Programme. The award criteria and evaluation procedure specific to Marie Sklodowska-Curie Actions (MSCA) are also described in the MSCA part of the Work Programme.
Submission and evaluation processes are described in the Online Manual.
4. Indicative time for evaluation and grant agreements:
Information on the outcome of evaluation (single-stage call): maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
5. Proposal templates, evaluation forms and model grant agreements (MGA):
Co...
1. Eligible countries: described in Annex A of the Work Programme.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
2. Eligibility and admissibility conditions: described in the MSCA part of the WorkProgramme.
Only legal entities from EU Member States and Associated Countries are eligible to participate in this action as beneficiaries as the aim of the action is to focus on European and national R&I programmes in Europe to support researchers at risk.
Proposal page limits and layout: please refer to Part B of the proposal template in the submission system below.
3. Evaluation:
Evaluation criteria, scoring and thresholds are described in Annex H of the Work Programme. The award criteria and evaluation procedure specific to Marie Sklodowska-Curie Actions (MSCA) are also described in the MSCA part of the Work Programme.
Submission and evaluation processes are described in the Online Manual.
4. Indicative time for evaluation and grant agreements:
Information on the outcome of evaluation (single-stage call): maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
5. Proposal templates, evaluation forms and model grant agreements (MGA):
Coordination and Support Action:
Specific provisions and funding rates
Standard proposal template
Standard evaluation form
General MGA - Multi-Beneficiary
Annotated Grant Agreement
6. Additional provisions:
Horizon 2020 budget flexibility
Classified information
Members of consortium are required to conclude a consortium agreement, in principle prior to the signature of the grant agreement.
7. Open access must be granted to all scientific publications resulting from Horizon 2020 actions.
Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Open access to research data
The Open Research Data Pilot has been extended to cover all Horizon 2020 topics for which the submission is opened on 26 July 2016 or later. Projects funded under this topic will therefore by default provide open access to the research data they generate, except if they decide to opt-out under the conditions described in Annex L of the Work Programme. Projects can opt-out at any stage, that is both before and after the grant signature.
Note that the evaluation phase proposals will not be evaluated more favourably because they plan to open or share their data, and will not be penalised for opting out.
Open research data sharing applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available open access and need to describe their approach in a Data Management Plan.
Projects need to create a Data Management Plan (DMP), except if they opt-out of making their research data open access. A first version of the DMP must be provided as an early deliverable within six months of the project and should be updated during the project as appropriate. The Commission already provides guidance documents, including a template for DMPs. See the Online Manual.
Eligibility of costs: costs related to data management and data sharing are eligible for reimbursement during the project duration.
The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.
8. Additional documents:
1. Introduction WP 2018-20
3. Marie Sklodowska-Curie actions (MSCA) WP 2018-20
18. Dissemination, Exploitation and Evaluation WP 2018-20
General annexes to the Work Programme 2018-2020
Legal basis: Horizon 2020 Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda tiene efecto incentivador, por lo que el proyecto no puede haberse iniciado antes de la presentación de la solicitud de ayuda. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
H2020-MSCA-RR-2018 MSCA for researchers at risk Objective:Facilitate trans-national co-operation between European and national initiatives and programmes in support of researchers at risk,...
Sin info.
H2020-MSCA-RR-2018 MSCA for researchers at risk
en consorcio: Objective:Facilitate trans-national co-operation between European and national initiatives and programmes in support of researchers at risk,...
Cerrada hace 6 años | Próxima convocatoria prevista para el mes de